Ductal Carcinoma in Situ and Cause-specific Mortality Among Younger and Older Postmenopausal Women: the Women's Health Initiative

Overview

Journal Breast Cancer Res Treat

Specialty Oncology

Date 2024 May 10

PMID 38730133

Authors

Kathy Pan

Rebecca A Nelson

Rowan T Chlebowski

Rita Piela

Maeve Mullooly

Michael S Simon

Thomas E Rohan

Jean Wactawski-Wende

JoAnn E Manson

Joanne E Mortimer

Dorothy Lane

Laura Kruper

Affiliations

Soon will be listed here.

Abstract

Background: Whether DCIS is associated with higher breast cancer-specific and all-cause mortality is unclear with few studies in older women. Therefore, we examined DCIS and breast cancer-specific, cardiovascular (CVD)-specific, and all-cause mortality among Women's Health Initiative (WHI) Clinical Trial participants overall and by age (< 70 versus ≥ 70 years).

Methods: Of 68,132 WHI participants, included were 781 postmenopausal women with incident DCIS and 781 matched controls. Serial screening mammography was mandated with high adherence. DCIS cases were confirmed by central medical record review. Adjusted multivariable Cox proportional hazard regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CI). Kaplan Meier (KM) plots were used to assess 10-year and 20-year mortality rates.

Results: After 20.3 years total, and 13.2 years median post-diagnosis follow-up, compared to controls, DCIS was associated with higher breast cancer-specific mortality (HR 3.29; CI = 1.32-8.22, P = 0.01). The absolute difference in 20-year breast cancer mortality was 1.2% without DCIS and 3.4% after DCIS, log-rank P = 0.026. Findings were similar by age (< 70 versus ≥ 70 years) with no interaction (P interaction = 0.80). Incident DCIS was not associated with CVD-specific mortality (HR 0.77; CI-0.54-1.09, P = 0.14) or with all-cause mortality (HR 0.96; CI = 0.80-1.16, P = 0.68) with similar findings by age.

Conclusions: In postmenopausal women, incident DCIS was associated with over three-fold higher breast cancer-specific mortality, with similar findings in younger and older postmenopausal women. These finding suggest caution in using age to adjust DCIS clinical management or research strategies.

References

Brinton L, Sherman M, Carreon J, Anderson W . Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst. 2008; 100(22):1643-8. PMC: 2720764. DOI: 10.1093/jnci/djn344. View

Berkman A, Cole B, Ades P, Dickey S, Higgins S, Trentham-Dietz A . Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2014; 148(2):407-13. PMC: 4372117. DOI: 10.1007/s10549-014-3168-3. View

He W, Lindstrom L, Hall P, Czene K . Cause-specific mortality in women with breast cancer in situ. Int J Cancer. 2016; 140(11):2414-2421. DOI: 10.1002/ijc.30413. View

Schonberg M, Marcantonio E, Ngo L, Li D, Silliman R, McCarthy E . Causes of death and relative survival of older women after a breast cancer diagnosis. J Clin Oncol. 2011; 29(12):1570-7. PMC: 3138627. DOI: 10.1200/JCO.2010.33.0472. View

Dignam J, Huang L, Ries L, Reichman M, Mariotto A, Feuer E . Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts. Cancer. 2009; 115(22):5272-83. PMC: 2783951. DOI: 10.1002/cncr.24617. View

Boekel N, Schaapveld M, Gietema J, Rutgers E, Versteegh M, Visser O . Cardiovascular morbidity and mortality after treatment for ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2014; 106(8). PMC: 4151854. DOI: 10.1093/jnci/dju156. View

Elshof L, Schmidt M, Rutgers E, van Leeuwen F, Wesseling J, Schaapveld M . Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ. Ann Surg. 2017; 267(5):952-958. PMC: 5916471. DOI: 10.1097/SLA.0000000000002239. View

Alvarado R, Lari S, Roses R, Smith B, Yang W, Mittendorf E . Biology, treatment, and outcome in very young and older women with DCIS. Ann Surg Oncol. 2012; 19(12):3777-84. PMC: 3854959. DOI: 10.1245/s10434-012-2413-4. View

Jenkins E, Deal A, Anders C, Prat A, Perou C, Carey L . Age-specific changes in intrinsic breast cancer subtypes: a focus on older women. Oncologist. 2014; 19(10):1076-83. PMC: 4200998. DOI: 10.1634/theoncologist.2014-0184. View

10.

Anderson G, Manson J, Wallace R, Lund B, Hall D, Davis S . Implementation of the Women's Health Initiative study design. Ann Epidemiol. 2003; 13(9 Suppl):S5-17. DOI: 10.1016/s1047-2797(03)00043-7. View

11.

Prentice R, Caan B, Chlebowski R, Patterson R, Kuller L, Ockene J . Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006; 295(6):629-42. DOI: 10.1001/jama.295.6.629. View

12.

Chlebowski R, Aragaki A, Prentice R . Dietary Moderation and Deaths From Breast Cancer. J Clin Oncol. 2020; 38(26):3071-3072. DOI: 10.1200/JCO.20.01218. View

13.

Chlebowski R, Kuller L, Prentice R, Stefanick M, Manson J, Gass M . Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 2009; 360(6):573-87. PMC: 3963492. DOI: 10.1056/NEJMoa0807684. View

14.

Chlebowski R, Anderson G, Aragaki A, Manson J, Stefanick M, Pan K . Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials. JAMA. 2020; 324(4):369-380. PMC: 7388026. DOI: 10.1001/jama.2020.9482. View

15.

Rich-Edwards J, Corsano K, Stampfer M . Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol. 1994; 140(11):1016-9. DOI: 10.1093/oxfordjournals.aje.a117191. View

16.

Hwang E, Solin L . De-Escalation of Locoregional Therapy in Low-Risk Disease for DCIS and Early-Stage Invasive Cancer. J Clin Oncol. 2020; 38(20):2230-2239. PMC: 7343434. DOI: 10.1200/JCO.19.02888. View

17.

Mannu G, Wang Z, Broggio J, Charman J, Cheung S, Kearins O . Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study. BMJ. 2020; 369:m1570. PMC: 7251423. DOI: 10.1136/bmj.m1570. View

18.

Giannakeas V, Sopik V, Narod S . Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Cancer. JAMA Netw Open. 2020; 3(9):e2017124. PMC: 7495235. DOI: 10.1001/jamanetworkopen.2020.17124. View

19.

Piccart M, Hilbers F, Bliss J, Caballero C, Frank E, Renault P . Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid Tumors. J Clin Oncol. 2020; 38(34):4120-4129. DOI: 10.1200/JCO.20.01382. View

20.

Visvanathan K, Fabian C, Bantug E, Brewster A, Davidson N, DeCensi A . Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2019; 37(33):3152-3165. DOI: 10.1200/JCO.19.01472. View